Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae
- PMID: 2271712
- DOI: 10.1021/bi00503a018
Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae
Abstract
A human liver cytochrome P-450 (P-450) IIIA4 cDNA clone was inserted behind an alcohol dehydrogenase promoter in the plasmid vector pAAH5 and expressed in Saccharomyces cerevisiae (D12 and AH22 strains). A cytochrome P-450 with typical spectral properties was expressed at a level of approximately 8 x 10(5) molecules/cell in either strain of yeast. The expressed P-450 IIIA4 had the same apparent monomeric Mr as the corresponding protein in human liver microsomes (P-450NF) and could be isolated from yeast microsomes. Catalytic activity of the yeast microsomes toward putative P-450 IIIA4 substrates was seen in the reactions supported by cumene hydroperoxide but was often lower and variable when supported by the physiological donor NADPH. The catalytic activity of purified P-450 IIIA4 was also poor in some systems reconstituted with rabbit liver NADPH-P-450 reductase and best when both the detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate and a lipid extract (from liver or yeast microsomes) or L-alpha-1,2-dilauroyl-sn-glycero-3-phosphocholine were present. Under these conditions the expressed P-450 IIIA4 was an efficient catalyst for nifedipine oxidation, 6 beta-hydroxylation of testosterone and cortisol, 2-hydroxylation of 17 beta-estradiol and 17 alpha-ethynylestradiol, N-oxygenation and 3-hydroxylation of quinidine, 16 alpha-hydroxylation of dehydroepiandrosterone 3-sulfate, erythromycin N-demethylation, the 10-hydroxylation of (R)-warfarin, the formation of 9,10-dehydrowarfarin from (S)-warfarin, and the activation of aflatoxins B1 and G1, sterigmatocystin, 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (both + and - diastereomers), 3,4-dihydroxy-3,4-dihydrobenz[a]anthracene, 3,4-dihydroxy-3,4-dihydro-7, 12-dimethylbenz[a]anthracene, 9,10-dihydroxy-9,10-dihydrobenzo[b]fluoranthene, 6-aminochrysene, and tris(2,3-dibromopropyl) phosphate to products genotoxic in a Salmonella typhimurium TA1535/pSK1002 system where a chimeric umuC' 'lacZ plasmid is responsive to DNA alkylation. Reaction rates were stimulated by 7,8-benzoflavone and inhibited by rabbit anti-P-450 IIIA (anti-P-450NF), troleandomycin, gestodene, and cimetidine. Evidence was obtained that rates of reduction of ferric P-450 IIIA4 in yeast microsomes and the reconstituted systems are slow and at least partially responsible for the lower rates of catalysis seen in these systems (relative to liver microsomes). The results of these studies with a defined protein clearly demonstrate the ability of P-450 IIIA4 to catalyze regio- and stereoselective oxidations with a diverse group of substrates, and this enzyme appears to be one of the most versatile catalysts in the P-450 family.
Similar articles
-
Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.Eur J Biochem. 1990 Dec 27;194(3):889-96. doi: 10.1111/j.1432-1033.1990.tb19483.x. Eur J Biochem. 1990. PMID: 2269307
-
Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.Cancer Res. 1989 Nov 15;49(22):6304-12. Cancer Res. 1989. PMID: 2509067
-
Expression of a rat liver microsomal cytochrome P-450 catalyzing testosterone 16 alpha-hydroxylation in Saccharomyces cerevisiae: vitamin D3 25-hydroxylase and testosterone 16 alpha-hydroxylase are distinct forms of cytochrome P-450.J Biochem. 1988 May;103(5):858-62. doi: 10.1093/oxfordjournals.jbchem.a122361. J Biochem. 1988. PMID: 3053677
-
[Cytochrome P-450 in human fetal liver. Properties of P-450 HFLa,a form of cytochrome P-450 in human fetal livers].Yakugaku Zasshi. 1991 Mar;111(3):158-69. doi: 10.1248/yakushi1947.111.3_158. Yakugaku Zasshi. 1991. PMID: 2066864 Review. Japanese.
-
Metabolism of 17 alpha-ethynylestradiol in humans.Life Sci. 1990;47(22):1981-8. doi: 10.1016/0024-3205(90)90431-p. Life Sci. 1990. PMID: 2273938 Review.
Cited by
-
The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways.J Virol. 2009 Oct;83(20):10557-70. doi: 10.1128/JVI.00330-09. Epub 2009 Aug 12. J Virol. 2009. PMID: 19706713 Free PMC article.
-
Exposure-response relationships and drug interactions of sirolimus.AAPS J. 2004 Oct 15;6(4):e28. doi: 10.1208/aapsj060428. AAPS J. 2004. PMID: 15760093 Free PMC article.
-
Role of cytochrome P450 in drug interactions.Nutr Metab (Lond). 2008 Oct 18;5:27. doi: 10.1186/1743-7075-5-27. Nutr Metab (Lond). 2008. Retraction in: Nutr Metab (Lond). 2014 Feb 14;11(1):11. doi: 10.1186/1743-7075-11-11. PMID: 18928560 Free PMC article. Retracted.
-
Human cytochromes P450: evolution and cDNA-directed expression.Environ Health Perspect. 1992 Nov;98:81-5. doi: 10.1289/ehp.929881. Environ Health Perspect. 1992. PMID: 1486867 Free PMC article.
-
Accumulation of mitochondrial P450MT2, NH(2)-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with beta-naphthoflavone. A role in the metabolism of neuroactive drugs.J Biol Chem. 2000 Nov 3;275(44):34415-23. doi: 10.1074/jbc.M004431200. J Biol Chem. 2000. PMID: 10915793 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases